Six-Month Response to Delamanid Treatment in MDR TB Patients

被引：29

作者：

Hewison, Cathy ^{[1
]}

Ferlazzo, Gabriella ^{[2
]}

Avaliani, Zaza ^{[3
]}

Hayrapetyan, Armen ^{[4
]}

Jonckheere, Sylvie ^{[5
]}

Khaidarkhanova, Zarema ^{[6
]}

Mohr, Erika ^{[2
]}

Sinha, Animesh ^{[7
]}

Skrahina, Alena ^{[8
]}

Vambe, Debrah ^{[9
]}

Vasilyeva, Irina ^{[10
]}

Lachenal, Nathalie ^{[11
]}

Varaine, Francis ^{[1
]}

机构：

[1] Med Sans Frontieres, Paris, France

[2] Med Sans Frontieres, Cape Town, South Africa

[3] Natl Ctr TB & Lung Dis, Tbilisi, Georgia

[4] Minist Hlth, Natl TB Control Ctr, Yerevan, Armenia

[5] Med Sans Frontieres, Johannesburg, South Africa

[6] Republican TB Dispensary, Grozny, Chechnya, Russia

[7] Med Sans Frontieres, Minsk, BELARUS

[8] Republican Res & Pract Ctr Pulmonol & TB, Minsk, BELARUS

[9] Swaziland Natl TB Control Program, Mbabane, Swaziland

[10] IM Sechenov First MSMU, Res Inst Phthisiopulmonol, Moscow, Russia

[11] Med Sans Frontieres, Geneva, Switzerland

来源：

EMERGING INFECTIOUS DISEASES | 2017年 / 23卷 / 10期

关键词：

D O I：

10.3201/eid2310.170468

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Delamanid, recently available for the treatment of multidrug-resistant tuberculosis (MDR TB), has had limited use outside clinical trials. We present the early treatment results for 53 patients from 7 countries who received a delamanid-containing treatment for MDR TB. Results show good tolerability and treatment response at 6 months.

引用

页码：1746 / 1748

页数：3

共 50 条

[31] Six-month depot formulation of leuprorelin acetate in the treatment of prostate cancer
Sethi, Rajni
Sanfilippo, Nicholas
CLINICAL INTERVENTIONS IN AGING, 2009, 4 : 259 - 267
[32] A six-month randomized controlled trial of exercise and pyridostigmine in the treatment of fibromyalgia
Jones, K. D.
Burckhardt, C. S.
Deodhar, A. A.
Perrin, N. A.
Hanson, G. C.
Bennett, R. M.
ARTHRITIS AND RHEUMATISM, 2008, 58 (02): : 612 - 622
[33] Comparison of chlorthalidone, propranolol and bopindolol in six-month treatment of arterial hypertension
Bagatin, J
Sardelic, S
Pivac, N
Polic, S
Ljutic, D
Rakic, D
Naranca, M
Bojic, L
Kovacic, Z
Rumboldt, Z
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1998, 18 (02) : 73 - 78
[34] Six-month topiramate treatment reduces body weight and blood pressure
Prud'homme, D
Fitchet, M
Almeras, N
Dumont, M
Tremblay, A
Després, JP
OBESITY RESEARCH, 2003, 11 : A114 - A114
[35] HS-HA syndrome in the cat - Six-month treatment with fluoxetine
Dramard, V
POINT VETERINAIRE, 2004, 35 (248): : 78 - 78
[36] Six-month compliance with antidepressant medication in the treatment of major depressive disorder
Demyttenaere, Koen
Adelin, Albert
Patrick, Mesters
Walthere, Dewe
Katrien, De Bruyckere
Michele, Sangeleer
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (01) : 36 - 42
[37] The effect of CPAP titration methodology on six-month compliance and treatment satisfaction
Zachek, M
Rosenthal, L
Hansbrough, J
Gfuellner, F
Betz, S
Pla-Ferrer, T
Nash, M
Strobel, R
SLEEP, 2005, 28 : A178 - A179
[38] Age disparities in six-month treatment retention for opioid use disorder
Mintz, Carrie M.
Presnall, Ned J.
Sahrmann, John M.
Borodovsky, Jacob T.
Glaser, Paul E. A.
Bierut, Laura J.
Grucza, Richard A.
DRUG AND ALCOHOL DEPENDENCE, 2020, 213
[39] Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort
Koirala, S.
Borisov, S.
Danila, E.
Mariandyshev, A.
Shrestha, B.
Lukhele, N.
Dalcolmo, M.
Shakya, S. R.
Miliauskas, S.
Kuksa, L.
Manga, S.
Aleksa, A.
Denholm, J. T.
Khadka, H. B.
Skrahina, A.
Diktanas, S.
Ferrarese, M.
Bruchfeld, J.
Koleva, A.
Piubello, A.
Koirala, G. S.
Udwadia, Z. F.
Palmero, D. J.
Munoz-Torrico, M.
Gc, R.
Gualano, G.
Grecu, V., I
Motta, I
Papavasileiou, A.
Li, Y.
Hoefsloot, W.
Kunst, H.
Mazza-Stalder, J.
Payen, M-C
Akkerman, O. W.
Bernal, E.
Manfrin, V
Matteelli, A.
Hamdan, H. Mustafa
Marcos, M. Nieto
Cadinanos Loidi, J.
Cebrian Gallardo, J. J.
Duarte, R.
Escobar Salinas, N.
Gomez Rosso, R.
Laniado-Laborin, R.
Martinez Robles, E.
Quiros Fernandez, S.
Rendon, A.
Solovic, I
PULMONOLOGY, 2021, 27 (05): : 403 - 412
[40] Vitamin E treatment in patients with nonalcoholic steatohepatitis: A six-month, open-label study of sixteen patients
Yakaryilmaz, F
Guliter, S
Ozenirler, S
Erdem, O
Akyol, G
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2004, 65 (03): : 266 - 277

← 1 2 3 4 5 →